Connor, Clark & Lunn Investment Management (CC&L)’s UroGen Pharma URGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-16,188
| Closed | -$243K | – | 1709 |
|
|
2024
Q1 | $243K | Sell |
16,188
-29,789
| -65% | -$447K | ﹤0.01% | 1342 |
|
|
2023
Q4 | $690K | Buy |
45,977
+16,211
| +54% | +$243K | ﹤0.01% | 963 |
|
|
2023
Q3 | $417K | Buy |
29,766
+8,260
| +38% | +$116K | ﹤0.01% | 1064 |
|
|
2023
Q2 | $223K | Buy |
+21,506
| New | +$223K | ﹤0.01% | 1171 |
|